Long COVID at 2-years
Two very interesting papers have just been published on the 2-year follow up of over 100,000 people with Covid and millions of uninfected controls: In a new edition…
Two very interesting papers have just been published on the 2-year follow up of over 100,000 people with Covid and millions of uninfected controls: In a new edition…
“Because COVID-19 is still around, reports of people getting reinfected with COVID-19 a second, third or even fourth time are becoming more common. The safest bet in reducing…
Very interesting and relevant interview (text and audio) with Prof. Danny Altmann about Long COVID and his recently published Nature review on the immunology of Long Covid. “My…
World’s largest study of long COVID will evaluate potential therapies for brain fog, sleep disruption and more. The US National Institutes of Health (NIH) announced yesterday that it…
The 2nd official peer-reviewed article generated by the Long COVID project has just been published by Viruses MDPI: The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings…
Very interesting opinion article on Long COVID published by Los Angeles Times. “In a world where most pandemic safety protocols have evaporated, where is the sense of urgency to treat, or…
This new review article published by the Molecular Psychiatry journal presents an overview of Published epidemiology, symptoms, and risk factors of Long COVID. This review also summarises potential pathophysiological mechanisms and biomarkers for precise prevention,…
The Lancet Respiratory Medicine has just published two excellent Long COVID reviews: the first one on the multi-system sequelae and the second one on the mechanisms of brain/neurologic…
Do not miss this very interesting editorial published in The Lancet Respiratory Medicine journal. “Now, more than 3 years after the emergence of SARS-CoV-2, at least 65 million…
A new study from Germany analysed the differences in cortical thickness between clinical subgroups based on 3T-MRI scans & signature inflammatory markers in n=120 participants comprising (1) healthy never-infected controls, (2)…